Expression of human clotting factor Ⅸ mediated by recom- binant lentiviral vector in cultured cells and hemophilia B mice

Hemophilia B, a serious bleeding disorder, is an inherited X chromosome-linked disease for the deficiency or inactivity of human clotting factor Ⅸ (hFⅨ). Though factor substitution therapy has greatly improved the lives of hemophiliac patients, there are still limitations to the current treatment, which have triggered interest in alternative treatments by gene therapy[1]. Based on preclinical studies in rabbits[2], our lab had first initiated an ex vivo gene therapy clinical trial whereby a…     

Development in the research of molecular mechanism of Alzheimer’s disease

Alzheimer's disease (AD) is a kind of central nervous system disease. The cause of AD is unclear. It is found that the remarkable histopathological characters of AD are senile plaques and neurofibrillary tangles. β-amyloid plays an important role in the formation of senile plaques and the abnormal phosphorylation of Tau protein is the main reason of neurofibrillary tangles. Apolipoprotein E is correlated to AD' s access, and the third pathological character-AMY plaque perhaps represents a new cause of AD. Presenlin and proteinaceous infectious particles are also related with AD. A summary of molecular mechanism for AD and the development of research is presented.     

A CASE REPORT OF MULTIPLE MYELOMA ASSOCIATED WITH RAYNAUD'S PHENOMENA AND DRY NECROSIS IN THE FINGER TIPS (in Chinese)

Multiple myeloma is a malignant disease of the plasma cells which have the function of secreting globulins. Excessive proliferation of abnormal plasma cells leads to hyperglobulinemia, which is mainly manifested by an increase in immuno—globulins. The case presented here is a myeloma of IgG type. There is marked decrease in normal immuno-globulins, thus causing an increase in viscosity of the blood and a resultant spasm of the arterioles in the     

Investigation of Prevalence Rate of Acute Severe Altitude Disease of Construction Groups at High Altitude

Objective： To know the prevalence rate of the acute severe altitude disease of the crowds who are working on the high altitude and the influential foctors upon the people. Method By epidemiology, a survey of 27606 persons who are working on the plateau has been made in the past three years, of which 229 persons had got the disease. 8175 persons who had received finer basic preventions in the group （Group A）, has been compared with 19430 persons who had a weak or no basic provention in the group （ Group B） ; the groups working on the plateau with 3 different elevations of above - 3600, - 4600 ＆ 5072 meters sea level have been compared. Resuts： The prevalence rate is 0.83 % in total groaps, of wich, high altitude pulmonary edema is 0.50%, high altitude cerebral edema is 0.28%, the patients who has got both the above diseases is 0.05%. The prevalance rates of the above in Group B and those of higher elevation are higher than those in Group A. 0.32% in Group A, and 1.04% in Group B. （x^2 = 36.95, p 〈 0.001） ;the prevalence rate on the 3 different high elevations are 0.00%, 0.68% and 1.34% in proper order. The prevalence rate of individuals groups in the highest 4.82% （the first year） and 2.26% （the next year ） and all the diseases came on the groups working on the highest elevation areas. Conclusion： The prevalence rate of acute severe plateau disease is very stem, the main influential factors are the height above the sea level, and the level of basic prvention for the crowds. Enhancing the protection of the labourers and medical safeguard, and social psychological adaption can cut down the prevalence rate, and this is the first important problem to solve for the plateau medicine and support from the society.     

An SNP polymorphism（-844C／T） in the promoter of catalase gene leads to differential expression

Imbalance of redox state has been associated with human diseases, such as cardiovascular diseases, Huntington‘s disease and Alzheimer‘s disease. Catalase, an important antioxidant enzyme, decomposes H202 into O2 and H2O, therefore limiting the deleterious effect of the reactive oxygen species (ROS). Previous study showed that a C-T polymorphism, located at -844 bp from the translational start site of catalase, is strongly associated with essential hypertension in an isolated Chinese population of Xiangchang country, Anhui Province. To explore the impact of SNP-844C/T on the expression of catalase, human catalase promoters containing either SNP-844C or T variant were subcloned into the pGL3Basic luciferase vector.     

Generation of VP5 deficient mutant of infectious bursal disease virus strain HZ2

Infectious bursal disease virus (IBDV) is one of the most significant viral pathogens in chickens[1]. It causes high mortality in young chickens and establishes an immunosuppression state by destroying the precursorsInfectious bursal disease virus (IBDV) …     

Expression of human clotting factor Ⅸ mediated by recom- binant lentiviral vector in cultured cells and hemophilia B mice

To explore the expression of human clotting factor Ⅸ (hFⅨ) cDNA in vitro and the feasibility of gene therapy for hemophilia B mice mediated by recombinant lentiviral vector, a recombinant hFⅨ lentiviral vector driven by ubiquitin-C promoter, FUXW, and by ABP liver specific promoter, FAXW, was constructed respectively. Recombinant lentivirus was harvested from 293T cells by calcium phosphate-mediated transient cotransfection of three plasmids (transgene vector, CMV腞8.2, VSV-G). hFⅨ expression was detected in supernatant of 293T, BHK and L-02 cells infected with FUXW virus, whereas higher expression of hFⅨ levels (630 ng/106 cells/48 h) was detected only in L-02 cells infected with FAXW virus. Serum hFⅨ antigen was detected in all hemophilia B mice treated with FAXW virus by tail vein injection, an efficiency level of hFⅨ was observed (45 ng/mL, approximately 1% of normal human levels), the expression lasted for more than 60 d. The results indicated that HIV-based lentiviral vectors offer a promising approach to the gene therapy of hemophilia B.     

Design and Implementation of Visualized Workflow Modeling System Based on B/S Structure

According to the necessity of flexible workflow management system, the solution to set up the visualized workflow modelling system based on B/S structure is put forward, which conforms to the relevant specifications of WfMC and the workflow process definition meta-model. The design for system structure is presented in detail, and the key technologies for system implementation are also introduced. Additionally, an example is illustrated to demonstrate the validity of system.     

Preparation of a recombinant adeno-associated viral vector with a mutation of human factor Ⅸ in large scale and its expression in vitro and in vivo

A series of adeno-associated viral vectors containing a mutation of human factor Ⅸ (hFⅨR338A) with different regulation elements were constructed and used to transduce cell lines. The plasmids and the stable transduction cell clones with high expression level of hFⅨR338A were obtained by selecting and optimizing, and then, the recombinant adeno-associated viral vector with hFⅨR338A was prepared via novel rHSV/AAV hybrid virus packaging system on a large scale, which contained the capsid protein genes. A method for producing rAAV-hFⅨR338A viral stocks on a large scale and higher titer was established, which can be used for industrial purpose. The titer of rAAV-hFⅨR338A was more than 1.25×10¹² particle/mL, and then, a mammalian cell line, C2C12 and the factor Ⅸ knock-out mice were transfected with the rAAV-hFⅨR338A in vitro and in vivo. The results show that the high-level expression of rAAV-hFⅨR338A was achieved in cell line and hemophilia B mice. It reached at (2551.32±92.14) ng·(10⁶ cells)^-1·(24 h)^-1 in C2C12 cell in vitro and had a peak concentration of 463.28 ng/mL in mice treated with rAAV-hFⅨR338A, which was as high as the expression of rAAV-hFⅨ-wt (2565.76±64.36) ng·(10⁶ cells)^-1·(24 h)^-1 in C2C12 and 453.92 ng/mL in the mice treated with rAAV-hFⅨ-wt) in vitro and in vivo, there is no any difference between two groups, but the clotting activity of hFⅨR338A is about 2.46 times higher than that of hFⅨ-wt. It was first reported that a mutation of human factor Ⅸ was used into gene therapy research for hemophilia B, meanwhile, a novel packaging system, rAAV/HSV was used for preparation of rAAV-hFⅨR338A on a large scale, which laid the foundation of industrial production for applying rAAV viral stocks to gene therapy clinical trial for hemophilia B mediated with rAAV-hFⅨ.     

Ultrastructure of spermatozoa of Bullacta exarata （philippi） and its significance on reproductive evolution and physio-ecological adaptation

The morphology and ultrastructure of Bullacta exarata spermatozoa observed by light and transmission electron microscopy are presented in this paper. The spermatozoon is composed of head with a simple acrosomal complex and an elongated nucleus, and tail with a midpiece, principal piece and an end piece. The midpiece consists of a mitochondrial ring, and the principal piece is composed of axoneme and lateral fin. The structure of B. exarata spermatozoa differs significantly from that of other gastropods, especially in the lateral fin and the principal piece, which was described scarcely before. A comparison is made between B. exarata and other gastropods, and its significance on reproductive evolution and physio-ecological adaptation is preliminarily discussed.     

汉滩病毒囊膜糖蛋白g2基因重组腺病毒的构建与表达

获得汉滩病毒G2 基因 ,构建其重组腺病毒并在HEK2 93细胞中包装表达 ,为研究汉滩病毒基因疫苗提供了实验基础。设计引物采用PCR从含汉滩病毒 \|76 1 1 8株M基因的M5 6质粒扩增出糖蛋白G2 基因片段 ,并将其克隆入腺病毒载体Adeno XviralDNA ,筛选获得重组腺病毒DNA ,转染HEK2 93细胞 ,包装、扩增后得到汉滩病毒G2 基因重组腺病毒原种 ;并在感染细胞内初步表达 ,用ELISA检测表达产物。得到了含汉滩病毒G2 基因的重组腺病毒 ,其滴度约为 1 0 10 pfu/mL ,同时在感染的HEK2 93细胞中检测到汉滩病毒糖蛋白G2 的表达。含汉滩病毒糖蛋白G2 基因重组腺病毒的成功构建 ,为研究汉滩病毒基因疫苗提供了实验基础     

A novel method for purification of recombinant adenoassociated virus vectors on a large scale

A novel method for recombinant adeno-associated virus (rAAV) purification on large scale is described. The method involves three steps, including chloroform treatment, PEG/NaCl precipitation and chloroform extraction. The whole procedure can be performed in four hours. Using this purification method, we can reproducibly obtain, from 4×10⁹ of proviral cells cultured in roller bottles, purified rAAV-GFP stocks with titers of around 5×10¹³ particles/mL and purity greater than 95%. The infectious titers of the vector stocks were up to 2×10 TU/mL, thus particle-to-infectivity rate was about 25. Under an electronic microscope, most rAAV particles appeared full and a few were in intermediate form. Empty particles were rarely seen. The purified rAAV-GFP stocks have been successfully used in in vitro and in vivo transfection experiments. Therefore, this new method offers a simple, rapid and cost-effective way for large-scale rAAV purification.     

Scalable manufacturing methodologies for improving adeno-associated virus-based pharmaprojects

Adeno-associated virus （AAV） is a promising viral vector and meets most requirements of being a safe biological agent. However, the commercialization of AAV has been hampered due to the limitation of large-scale production, and only a small number of clinical trials have been launched. In recent years, progresses in scalable manufacturing of AAV have dramatically improved AAV- based clinical researches, and have assisted the develop- ment of investigational drug products. An AAVl-based investigational product, Glybera, has been formally approved by European Commission for the treatment of lipoprotein lipase deficiency （LPLD）. Glybera was the first gene therapy product in the western world, and the pro- duction process involves a scalable baculovirus-insect cell system. However, many problems still need to be solved to improve the productivity and quality of AAV. The present review gives critical insights into current state-of-the-art scalable producing methodologies of AAV, such as bacu-lovirus-insect cell system, HSV complementation system, and Ad complementation system, along with a discussion on the problems, solutions, and developmental trends.Novel AAV-producing platforms in Saccharomyces cere- visiae and vaccinia virus complementation system will also be discussed.     

重组腺相关病毒基因药物三种滴度的比较与分析

采用酶联免疫吸附测定(ELISA)、实时荧光定量聚合酶链反应(Q-PCR)和转导方法对重组腺相关病毒(rAAV)的衣壳滴度、基因组滴度、转导滴度进行定量,并比较衣壳滴度/基因组滴度(P/GC)和基因组滴度/转导滴度(GC/TU).实验结果表明:3批rAAV的平均衣壳滴度为3.65×10¹³ P·mL^-1,平均基因组滴度为8.67×10¹¹ GC·mL^-1,平均转导滴度为9.85×10⁹ TU·mL^-1,P/GC平均值为41.70,GC/TU平均值为88.20,P/GC和GC/TU平均值接近于AAV2标准品,说明文中方法的制备工艺成熟、稳定,制备的rAAV感染活性较高.     

Generation of a recombinant herpes simplex virus which can provide packaging function for recombinant adeno-associated virus

The generation of a recombinant HSV (rHSV) that can provide packaging function for rAAV production is described. A set of cosmids including cos48, cos28, cos6, cosl4 and cos56, which represents the HSV-1 genome was used for generation of this rHSV.Rep andcap genes of AAV-2 were inserted intoXba I site ofUL2 gene on cod, generating cos6rcΔUL2. After being digested withPac I, cos6-rcΔUL2 and the other 4 cosmids were cotransfected into BHK-21 cells. The recombinant virus HSV1-rc/ΔUL2 carryingrep andcap genes was generated due to the homologous recombination of the 5 cosmids. The results showed that the existence ofrep andcap genes on this rHSV was stable from passage to passage and the rHSV could support the packaging of rAAV either in cells transiently transfected with AAV vector or in stable cell line harboring AAV vector. Further modification of this rHSV and optimization of conditions involved in rAAV preparation may lead to a large-scale production of rAAV in the near future.     

Generation of a recombinant herpes simplex virus which can provide packaging function for recombinant adeno-associated

The generation of a recombinant HSV (rHSV) that can provide packaging function for rAAV production is described. A set of cosmids including cos48, cos28, cos6, cos14 and cos56, which represents the HSV-1 genome was used for generation of this rHSV. Rep and cap genes of AAV-2 were inserted into Xba Ⅰ site of UL2 gene on cos6, generating cos6-rcΔUL2. After being digested with Pac Ⅰ , cos6-rcΔUL2 and the other 4 cosmids were cotrans-fected into BHK-21 cells. The recombinant virus HSV1-rc/ΔUL2 carrying rep and cap genes was generated due to the homologous recombination of the 5 cosmids. The results showed that the existence of rep and cap genes on this rHSV was stable from passage to passage and the rHSV could support the packaging of rAAV either in cells transiently transfected with AAV vector or in stable cell line harboring AAV vector. Further modification of this rHSV and optimization of conditions involved in rAAV preparation may lead to a large-scale production of rAAV in the near future.     

不同血清型腺相关病毒在大鼠 DRG神经元转染效果的比较

摘要:目的 比较不同血清型腺相关病毒( AAV5、AAV6、AAV8 和 AAV9) 对背根神经节( DRG) 初级感觉神经元的转导效能。 方法 将 24 只雄性 SD 大鼠随机分为 8 组,分别通过 DRG 直接注射不同血清型腺相关病毒( AAV5、AAV6、AAV8 和 AAV9)载体,各组大鼠分别在转染后第 3 周和第 4 周取材,并在共聚焦显微镜下观测对大鼠 DRG初级感觉神经元的转染效果。 结果 组织切片的荧光结果显示,腺相关病毒各亚型的转染效果如下:转染 3 周,AAV9> AAV6> AAV8 > AAV5;转染 4 周,AAV9> AAV6> AAV8> AAV5。 其中,AAV9 载体对大鼠 DRG 神经元的转导效果较好。 结论 DRG 注射不同血清型腺相关病毒( AAV5、AAV6、AAV8 和 AAV9) 载体,AAV9 对 DRG 神经元的转导效能最佳。